¿ Aclara BioSciences Inc., of Hayward, Calif., named Bertram Rowland vice president and general counsel.

¿ Affymetrix Inc., of Santa Clara, Calif., appointed Ronald Verdoorn executive vice president, global manufacturing.

¿ Alerge Medical Inc., of San Francisco, appointed Jan Barker vice president of operations. Lawrence Goldberg was retained in a consultative role to act as vice president of marketing and research.

¿ Alexion Pharmaceuticals Inc., of New Haven, Conn., named Nancy Motola vice president, regulatory affairs and quality assurance, and Paula Craft senior director, quality assurance and compliance.

¿ AltaRex Corp., of Waltham, Mass., named Christopher Nicodemus senior vice president, medical and regulatory affairs.

¿ Amarillo Biosciences Inc., of Amarillo, Texas, appointed Kathleen Kelleher chief operating officer and vice president of business development.

¿ Ariad Pharmaceuticals Inc., of Cambridge, Mass., named Laurie Allen senior vice president, corporate development and legal affairs, and general counsel.

¿ ArQule Inc., of Medford, Mass., appointed Stephen Hill president and chief executive officer.

¿ AtheroGenics Inc., of Norcross, Ga., named Mark Colonnese vice president of finance and chief financial officer.

¿ Atlantic Pharmaceuticals Inc., of Raleigh, N.C., named as a director Martin Cleary, co-founder, president and CEO of CardioGene Therapeutics.

¿ Atugen Biotechnology GmbH, of Berlin, named Klaus Giese vice president of research.

¿ Biogen Inc., of Cambridge, Mass., promoted James Mullen to president and chief operating officer. It also named Burt Adelman vice president, medical research; Michael Booney vice president, sales and marketing; Joseph Davie senior vice president, research; Sylvie Gregoire vice president, regulatory affairs; and Mark Leuchtenberger, vice president, international.

¿ Cardiac Science Inc., of Irvine, Calif., named Michael Gioffredi vice president, sales and marketing, and Barry Klegerman, director of sales.

¿ Cell Therapeutics Inc., of Seattle, appointed Edward Kenney chief operating officer.

¿ Cellegy Pharmaceuticals Inc., of South San Francisco, appointed Jiro Hayashi special advisor, business development, in Japan.

¿ Cerus Corp., of Concord, Calif., named Robert Miller vice president of finance and chief financial officer.

¿ ChiRex Inc., of Stamford, Conn., appointed Michael Nicholds vice president, sales and marketing.

¿ Clinicor Inc., of Austin, Texas, appointed Janice Hutt, D. Patrick Hankey, and Ajay Ohir directors of business development.

¿ CombiChem Inc., of San Diego, named Mark Suto vice president, operations, at ChiroChem.

¿ Cor Therapeutics Inc., of South San Francisco, added Patrick Broderick as senior vice president, general counsel and corporate secretary; Lee Rauch, senior vice president, corporate development; Anne Randolph, vice president, development; and Peter Roddy, vice president finance.

¿ Coulter Pharmaceutical Inc., of Palo Alto, Calif., appointed Kent Iverson vice president, manufacturing; Kay Slocum vice president, human resources; and Cathy Akiyama vice president, marketing.